Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> Shanghai Pharmaceuticals (02607.HK) Full-Year Net Profit RMB5.725 Billion, Up 25.7%; Distributes RMB3.5 per 10 Shares
Recommend 3 Positive 2 Negative 0 |
||||
|
||||
|
Shanghai Pharmaceuticals (02607.HK) announced its 2025 annual results, with revenue of RMB283.58 billion, up 3% YoY. The company recorded a net profit of RMB5.725 billion, an increase of 25.7%, with an EPS of RMB1.54. A final dividend of RMB3.5 per 10 shares will be distributed. Excluding one-off gains and losses, the net profit for the year was RMB4.721 billion, a decline of 5.6%. (de/d) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
